Resource Library
Do you know of a resource that would be a great addition to our collection? Let us know!
Regulatory process
“The FDA must prioritize reviewing the first-ever application for an OTC birth control pill and announce a new date for the advisory committee meeting as soon as possible.”
— Free the Pill coalition
“We will not stop until birth control is over-the-counter and accessible for all people regardless of age, race, gender, class, or sexuality!”
— Lauren Schenck, age 20, #FreeThePill Youth Council, Advocates for Youth
“Providing patients with OTC access to the birth control pill is an easy call from a public health perspective as the health risks of pregnancy vastly outweigh those of oral contraceptive use.”
— David H. Aizuss, MD, American Medical Association Board Member
“The potential benefits here are enormous and have been documented through decades of research and data on the benefits of birth control access for all… The public support reflects the benefits of access as well: seventy percent of women of reproductive age are in favor of making birth control available over the counter without a prescription.”
— Oral Contraceptives (OCs) Over-the-Counter (OTC) Working Group
“Despite decades of proven safety and effectiveness, people still face immense barriers to getting birth control due to systemic inequities in our healthcare system… FDA has an important role to play in removing unnecessary barriers to provide individuals greater control over their reproductive lives and health.”
— Pro-Choice Caucus, United States House of Representatives
“RESOLVED, That the American Academy of Family Physicians write to the U.S. Food and Drug Administration (FDA) to encourage that adolescents, regardless of age, be included in the over-the-counter (OTC) oral contraceptives studies required by the FDA (e.g., label comprehension study, actual use study) to determine whether OTC access is appropriate for this population.”
— Congress of Delegates, American Academy of Family Physicians